Yield10 Bioscience to Present at the H.C. Wainwright Global Hybrid Investment Conference
May 19 2022 - 8:30AM
Yield10 Bioscience, Inc. (Nasdaq: YTEN) (“Yield10” or the
“Company”), an agricultural bioscience company, today announced
that President and CEO Oliver Peoples, Ph.D. will present a
corporate overview at the H.C. Wainwright Global Hybrid Investment
Conference. The conference is being held on May 23 – 26, 2022 at
the Fontainebleau Hotel in Miami Beach, FL.
Event: H.C. Wainwright Global Hybrid Investment
Conference Time: Available on demand as of 7:00 am
ET May 24 through May 26, 2022Webcast: Click this
link to view the presentation
About Yield10 Bioscience
Yield10 Bioscience, Inc. is an agricultural bioscience company
that is using its differentiated trait gene discovery platform, the
“Trait Factory”, to develop improved Camelina varieties to produce
proprietary seed products, and to discover high value genetic
traits for the agriculture and food industries. Our goals are to
efficiently establish a high value seed products business based on
developing superior varieties of Camelina for the production of
feedstock oils for renewable diesel, PHA bioplastics and omega-3
(DHA+EPA) oils, and to license our yield traits to major seed
companies for commercialization in major row crops, including corn,
soybean and canola. Yield10 is headquartered in Woburn, MA and has
an Oilseeds Center of Excellence in Saskatoon, Canada.
For more information about the Company, please visit
www.yield10bio.com, or follow the Company on Twitter, Facebook and
LinkedIn.
(YTEN-G)
Contacts:
Yield10 Bioscience:Lynne H. Brum, (617) 682-4693,
LBrum@yield10bio.com
Investor Relations: Bret Shapiro, (561) 479-8566,
brets@coreir.comManaging Director, CORE IR
Media Inquiries: Eric Fischgrund, eric@fischtankpr.com FischTank
PR
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Mar 2024 to Apr 2024
Yield10 Bioscience (NASDAQ:YTEN)
Historical Stock Chart
From Apr 2023 to Apr 2024